Research Site

Shenyang, Liaoning 110801

1 studies enrolling now · 6 studies all time

What they study most

Acute Coronary Syndrome, Anemia, Cancer, Diabetes, Hyperlipidemia, Mixed Dyslipidemia, Dyslipidemia, Heart Failure, Lung Cancer, Non-Small Cell Lung Cancer, Solid Tumors

Studies at this site

• JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation — Recruiting now
• Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk — Completed
• Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy — Stopped early
• Registrational Study With Omecamtiv Mecarbil (AMG 423) to Treat Chronic Heart Failure With Reduced Ejection Fraction — Completed
• Safety and Efficacy of Evolocumab in Combination With Statin Therapy in Adults With Diabetes and Hyperlipidemia or Mixed Dyslipidemia — Completed
• A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome — Completed